Literature DB >> 10444570

Vitamin D.

A J Brown1, A Dusso, E Slatopolsky.   

Abstract

The vitamin D endocrine systems plays a critical role in calcium and phosphate homeostasis. The active form of vitamin D, 1, 25-dihydroxyvitamin D(3) [1,25(OH)(2)D(3)], binds with high affinity to a specific cellular receptor that acts as a ligand-activated transcription factor. The activated vitamin D receptor (VDR) dimerizes with another nuclear receptor, the retinoid X receptor (RXR), and the heterodimer binds to specific DNA motifs (vitamin D response elements, VDREs) in the promoter region of target genes. This heterodimer recruits nuclear coactivators and components of the transcriptional preinitiation complex to alter the rate of gene transcription. 1,25(OH)(2)D(3) also binds to a cell-surface receptor that mediates the activation of second messenger pathways, some of which may modulate the activity of the VDR. Recent studies with VDR-ablated mice confirm that the most critical role of 1, 25(OH)(2)D(3) is the activation of genes that control intestinal calcium transport. However, 1,25(OH)(2)D(3) can control the expression of many genes involved in a plethora of biological actions. Many of these nonclassic responses have suggested a number of therapeutic applications for 1,25(OH)(2)D(3) and its analogs.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10444570     DOI: 10.1152/ajprenal.1999.277.2.F157

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  87 in total

1.  Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons.

Authors:  L D Brewer; V Thibault; K C Chen; M C Langub; P W Landfield; N M Porter
Journal:  J Neurosci       Date:  2001-01-01       Impact factor: 6.167

2.  Inhibition of cancer growth and induction of apoptosis by BGP-13 and BGP-15, new calcipotriene-derived vitamin D3 analogs, in-vitro and in-vivo studies.

Authors:  Liron Berkovich; Amnon C Sintov; Shimon Ben-Shabat
Journal:  Invest New Drugs       Date:  2012-06-02       Impact factor: 3.850

3.  Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn's disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral density.

Authors:  M T Abreu; V Kantorovich; E A Vasiliauskas; U Gruntmanis; R Matuk; K Daigle; S Chen; D Zehnder; Y-C Lin; H Yang; M Hewison; J S Adams
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

4.  The Association Between Antiepileptic Drugs and Bone Disease.

Authors:  Alison M. Pack
Journal:  Epilepsy Curr       Date:  2003-05       Impact factor: 7.500

5.  1,25-dihydroxyvitamin D3 treatment shrinks uterine leiomyoma tumors in the Eker rat model.

Authors:  Sunil K Halder; Chakradhari Sharan; Ayman Al-Hendy
Journal:  Biol Reprod       Date:  2012-04-19       Impact factor: 4.285

6.  Selective inhibition of the C5a chemotactic cofactor function of the vitamin D binding protein by 1,25(OH)2 vitamin D3.

Authors:  Anisha B Shah; Stephen J DiMartino; Glenda Trujillo; Richard R Kew
Journal:  Mol Immunol       Date:  2005-08-22       Impact factor: 4.407

7.  Causes of secondary hyperparathyroidism in a healthy population: the Tromsø study.

Authors:  Farahnaz Saleh; Rolf Jorde; Johan Sundsfjord; Egil Haug; Yngve Figenschau
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

8.  Hypovitaminosis D as predisposing factor for atrophic type A gastritis: a case-control study and review of the literature on the interaction of Vitamin D with the immune system.

Authors:  Antonio Antico; Renato Tozzoli; Davide Giavarina; Elio Tonutti; Nicola Bizzaro
Journal:  Clin Rev Allergy Immunol       Date:  2012-06       Impact factor: 8.667

9.  Inecalcitol, an analog of 1,25D3, displays enhanced antitumor activity through the induction of apoptosis in a squamous cell carcinoma model system.

Authors:  Yingyu Ma; Wei-Dong Yu; Alejandro A Hidalgo; Wei Luo; Remi Delansorne; Candace S Johnson; Donald L Trump
Journal:  Cell Cycle       Date:  2013-02-06       Impact factor: 4.534

10.  Vitamin D receptor expression is associated with improved overall survival in human glioblastoma multiforme.

Authors:  Débora G Salomón; María E Fermento; Norberto A Gandini; María J Ferronato; Julián Arévalo; Jorge Blasco; Nancy C Andrés; Jean C Zenklusen; Alejandro C Curino; María M Facchinetti
Journal:  J Neurooncol       Date:  2014-03-01       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.